Current role
Biotechnology · Healthcare
Board Member
2025-04-15–present
Adele Gulfo
Board Member
NewAmsterdam Pharma Co N.V. (NAMS)Equibles does not estimate personal net worth.
About Adele Gulfo
Adele Gulfo is recorded as Board Member at NewAmsterdam Pharma Co N.V. (NAMS) since April 15, 2025. NewAmsterdam Pharma Co N.V. reported in an 8-K filed April 17, 2025 that Adele Gulfo was appointed member of the Board, effective April 15, 2025. NewAmsterdam Pharma Co N.V. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at NewAmsterdam Pharma Co N.V. includes Michael Davidson (CEO), Willian H. Lewis, J.D., M.B.A. (Chairman), Ian Somaiya (CFO) and 3 others.
“On April 15, 2025, the board of directors (the "Board") of NewAmsterdam Pharma Company N.V. (the "Company") appointed Adele Gulfo to serve as a member of the Board.”
Affiliation history
-
Current
2025-04-15–present
Company network
Leadership on record at NewAmsterdam Pharma Co N.V.
- Michael Davidson CEO
- Willian H. Lewis, J.D., M.B.A. Chairman
- Ian Somaiya CFO
- Robert W. Gunning Chief Accounting Officer
- Mark C. McKenna Board Member
- Wouter Joustra Board Member